Detalhe da pesquisa
1.
The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins.
J Biol Chem
; 299(3): 102992, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758799
2.
Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
Mol Cell Proteomics
; 20: 100136, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391887
3.
Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V.
Mol Cell Proteomics
; 18(4): 622-641, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617155
4.
The homeobox transcription factor DUXBL controls exit from totipotency.
Nat Genet
; 56(4): 697-709, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509386
5.
Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance.
Cancers (Basel)
; 15(8)2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190191
6.
J-domain Proteins form Binary Complexes with Hsp90 and Ternary Complexes with Hsp90 and Hsp70.
J Mol Biol
; 435(17): 168184, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348754
7.
YAP localization mediates mechanical adaptation of human cancer cells during extravasation in vivo.
bioRxiv
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076880
8.
Distinct, gene-specific effect of heat shock on heat shock factor-1 recruitment and gene expression of CXC chemokine genes.
Cytokine
; 54(1): 61-7, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266308
9.
Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma.
Cancers (Basel)
; 13(19)2021 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638461
10.
SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma.
Oncogene
; 40(18): 3331-3346, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33850265
11.
Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance.
Cancer Res
; 81(11): 3051-3066, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33727228
12.
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.
Cell Rep Med
; 1(1)2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483558
13.
APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors.
Cell Rep
; 26(10): 2651-2666.e6, 2019 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30840888
14.
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.
Cold Spring Harb Mol Case Stud
; 2(6): a001263, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27900369
15.
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
Cancer Discov
; 5(5): 534-49, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25735773